GlassScriptPhysician profile
Annie M Diaz
NPI 1245726546
$1,733.93
in general payments reported to CMS, 2019-2025
19 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $324 · 2023: $364 · 2024: $274 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $421.11 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $272.86 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $215.13 | 2021-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $165.18 | 2025 | |
| Pfizer INC. | $126.05 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $89.69 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.19 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.42 | 2022-2025 | Lifevest |
| Medtronic, INC. | $63.64 | 2023-2025 | Symplicity G3, Abre, Enteer |
| Stryker Corporation | $36.00 | 2025 | Flowtriever |
| Esperion Therapeutics, INC. | $34.18 | 2021 | |
| Bard Peripheral Vascular, INC. | $29.66 | 2022 | |
| Amgen INC. | $26.98 | 2022-2025 | Repatha |
| Angiodynamics, INC. | $21.78 | 2023 | Auryon Laser System 100-120 Vac |
| Scpharmaceuticals INC. | $21.53 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.55 | 2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $16.21 | 2025 | Zepbound, Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $15.97 | 2023 | Eliquis |
| Abbott Laboratories | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.